Lipid peroxidation alterations in type 2 diabetic patients

Pakistan Journal of Biological Sciences

Volumn 13, Issue 15, 2010, Pages 723-730

  Marjani, A ^a  

^a GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Disease; Lipid peroxidation; Type 2 diabetic patients

Indexed keywords

ANTIOXIDANT; FREE RADICAL; MALONALDEHYDE;

ARTICLE; BLOOD; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HUMAN; LIPID PEROXIDATION; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANTIOXIDANTS; BLOOD GLUCOSE; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FREE RADICALS; HUMANS; LIPID PEROXIDATION; MALONDIALDEHYDE;

EID: 77957658157     PISSN: 10288880     EISSN: 18125735     Source Type: Journal    
DOI: 10.3923/pjbs.2010.723.730     Document Type: Article

References (94)

1. Acworth, I.N., D.R. McCabe and T. Maher, 1997. The Analysis of Free Radicals, Their Reaction Products and Antioxidants. In: Oxidants, Antioxidants and Free Radicals, Baskin, S.I. and H. Salem (Eds.). Taylor Francis, Washington DC.
2. Aljada, A., K. Thusu, D. Armstrong, T. Nicotera and P. Dandona, 1995. Increased carbonylation of proteins in diabetes mellitus [abstract 420]. Diabetes, 44: 113-113.
3. Anabela, R.P. and P.M. Carlos, 2006. Diabetes and mitochondrial function: Role of hyperglycaemia and oxidative stress. Toxicol. Applied Pharmacol., 212: 167-178.
4. Anderson, R.A., 1995. Chromium, glucose tolerance, diabetes and lipid metabolism. J. Adv. Med., 8: 37-49.
5. Anderson, R.A., N. Cheng, N.A. Bryden, M.M. Polansky, N. Cheng, J. Chi and J. Feng, 1997. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes, 46: 1786-1791.
6. Arai, K., S. Magushi and S. Fujii, H. Oikawa and N. Taniguchi, 1987. Glycation and inactivation of human CuZn superoxide dismutase: Identification of the in vitro glycated sites. J. Biol. Chem., 262: 16969-16972.
7. Armstrong, D., R. Sohal, R. Cutler and T. Slater, 1982. Free Radicals in Molecular Biology and Aging. Raven Press Publ, New York.
8. Asayama, K., N. Uchida, T. Nakane, H. Hayashibe and K. Dobashix et-al, 1993. Antioxidants in the serum of children with insulin-dependent diabetes mellitus. Free Radical Biol. Med., 15: 597-602.
9. Atalay, M. and D.E. Laaksonen, 2002. Oxidative stress and physical exercise. J. Sports Sci. Med., 1: 1-4.
10. Atli, T., K. Keven, A. Avci, S. Kutlay and N. Turkcaper et al, 2004. Oxidative stress and antioxidant-status in elderly diabetes mellitus and glucose intolerance patients. Arch. Gerontol. Geriatr., 39: 269-275.
11. Aydin, A., H. Orhan, A. Sayal, M. Ozata, G. Sahin and A. Isimer, 2001. Oxidative stress and nitric oxide related parameters in type II diabetes mellitus: Effects of glycemic control, din. Biochem., 34: 65-70.
12. Azizi, F., M.M. Guoya, P. Vazirian, P. Dolatshati and S. Habbibian, 2003a. Screening for type 2 diabetes in the Iranian national programme: a preliminary report. EastMediterr. Health J., 9: 1122-1127.
13. Azizi, F., M.M. Gouya, P. Vazirian, P. Dolatshahi and S. Habibian, 2003b. The diabetes prevention and control programme of the Islamic Republic of Iran. EastMediterr. Health J., 9: 1114-1121.
14. Berger, M.M. and R. Chiolero, 1995. Relations between copper, zinc and selenium intakes and malondialdehyde excretion after major burns. Burns., 21: 507-512.
15. Bhatia, S., M.S. Venkata, G.J. Kaur, P.K. Madhava and R. Shukla, 2003. Antioxidant status, lipid peroxidation and nitric oxide end products in patients of type 2 diabetes mellitus with nephropathy. Clin. Biochem., 36: 557-562.
16. Bolstein-Fujii, R.A. DiSilvestro, D. Frid, C. Katz and W. Malarkey, 1997. Short-term zinc supplementation in women with non-insulin-dependent diabetes mellitus: Effects on plasma 5-nucleotidase activities, insulin-like growth factor I concentrations and lipoprotein oxidation rates in vitro. Am. J. Nutr., 66: 639-642.
17. Bonnefont-Rousselot, D., J.P. Bastard, M.C. Jaudon and J. Delattre, 2000. Consequences of the diabetic status on the oxidant/antioxidant balance. Diabetes Metab., 26: 163-176.
18. Cederberg, J., S. Basu and U.J. Eriksson, 2001. Increased rate of lipid peroxidation and protein carbonylationin experimental diabetic pregnancy. Diabetologia, 44: 766-774.
19. Cerielloa, A., D. Giugliano, A. Quatraro, P. Dello-Russo and P.J. Lefebvre, 1991. Metabolic control may influence the increased superoxide generation in diabetic serum. Diabet. Med., 8: 540-542.
20. Ceriellob, A., N. Bortolotti, E. Falleti, C. Taboga and L. Tonutti et al., 1997. Total radical-trapping antioxidant parameter in NIDDM patients. Diabetes Care, 20: 194-197.
21. Chaumer, A.B., 1998. Zinc, insulin and diabetes. J. Am. Coll. Nutr., 17: 109-115.
22. Cigremis, Y., M. Kose, F. Ozgurlu, Y. Turkoz and M. Egri, 2003. The investigation of erythrocyte SOD, Cat and GPX antioxidant enzyme level in pateints with type 2 diabetes mellitus. G.U. J. Sci., 16: 239-244.
23. Collier, A., A. Rumiey, A.G. Rumley, R.P. John, P.L. John, D.O. Gordon and S. Micheal, 1992. Free radical activity and hemostatic factors in NIDDM patients with and without microalbuminuria. Diabetes, 41: 909-913.
24. Crabbe, M., 1987. Diabetic Complications: Scientific and Clinical Aspects. Churchill Livingston, Inc., New York.
25. Dandona, P., K. Thusu, S. Cook, B. Snyder, J. Makowski, D. Armstrong and T. Nicotera, 1996. Oxidative damage to DNA in diabetes mellitus. Lancet, 347: 444-445.
26. Davi, G., G. Ciabattoni, A. Consoli, A. Mezzetti and A. Falco et al., 1999. In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: Effects of improved metabolic control and vitamin E supplementation. Circulation, 99: 224-229.
27. Del Rio, D., A.J. Stewart and N. Pellegrini, 2005. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr. Metab. Cardiovas. Dis., 15: 316-328.
28. DiSilvestro, R.A., 2000. Zinc in relation to diabetes and oxidative disease. J. Nutr., 130: 1509S-1511S.
29. Evliaoglu, O., N. Kilicaslan, N. Uzuncan, B. Karaca, A. Kocaclebi, N. Yensel and S. Inci, 2002. Serum levels of Cu, Zinc, Mg in type 1 and 2 diabetic patients 17. Proceedings of the Turkish National Biochemical Congress, Sept. 12-14, IEEE Xplore, London, pp: 285-286.
30. Flemming, N, B.B. Mikkelsen, B.N. Jesper, R.A. Helle and G. Philippe, 1997. Plasma malondialdehyde as biomarker for oxidative stress: Reference interval and effects of life-style factors. Clin Chem., 43:1209-1214.
31. Fujiwara, Y., T. Kondo, Y. Kawakami and K. Murakamig, 1989. Decrease of the inhibition of lipid peroxidation by glutathione dependent system in erythrocytes of non-insulin dependent diabetes. Klin. Wochenschr., 67: 336-341.
32. Giugliano, D., A. Ceriello and G. Paolisso, 1996. Oxidative stress and diabetic vascular complications. Diabetes Care, 19: 257-267.
33. Gopaul, N.K., E.E. Anggard, A.I. Mallet, D.J. Bettendge, S.P. Wolff and J. Nourooz-Zadeh, 1995. Plasma 8-epi-PGF2 alpha levels are elevated in individuals with non-insulin dependent diabetes mellitus. FEBS Lett., 368: 225-229.
34. Griesmacher, A., M. Kindhauser, S.E. Andert, W. Schreiner and C. Toma et al., 1995. Enhanced serum levels of thiobarbituric-ac id-reactive substances in diabetes mellitus. Am. J. Med., 98: 469-475.
35. Guichardant, M., L. Valette-Talbi, C. Cavadini, G. Crozier and M. Berger, 1994. Malondialdehyde measurement in urine. J. Chromatogr., 655: 112-116.
36. Hecker, M. Haurand, V. Ullrich, U. Diczfalusy and S. Hammarstrom, 1987. Products, kinetics and substrate specificity of homogeneous thromboxane synthetase from human platelets: Development of a novel enzyme assay. Arch. Biochem. Biophys., 254: 124-135.
37. Higuchi, Y., 1982. Lipid peroxides and a-tocopherol in rat streptozotocin- induced diabetes mellitus. Acta. Med. Okayama., 36: 165-175.
38. Horie, S., H. Ishii and T. Suga, 1981. Changes in peroxisomal fatty acid oxidation in diabetic rat liver. J. Biochem., 90: 1691-1696.
39. Houstis, N, E.D. Rosen and E.S. Lander, 2006. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nat., 440: 944-948.
40. Hunt, J. and S.P.O. Wolff, 1991. Oxidative glycation and free radical production: A causal mechanism of diabetic complications. Free Rad. Res. Commun., 12: 115-123.
41. Jain, S.K., 1989. Hyperglycemia can cause membrane lipid peroxidation and osmotic fragility in human red blood cells. J. Biol. Chem., 264: 21340-21345.
42. Jennings, P.E., M. McLaren, N.A. Scott, A.R. Saniabadi and J.J. Belch, 1991. The relationship of oxidative stress to thrombotic tendency in type 1 diabetic patients with retinopathy. Diabet. Med., 8: 860-865.
43. Johansen, J.S., A.K. Harris, D.J. Rychly and A. Ergul, 2005. Review: Oxidative stress and the use of antioxidants in diabetes: Linking basic science to clinical practice. Cardiovas. Diabetol., 4: 5-5.
44. Joseph, E.L., G.D. Ira, B.A. Maddux and G.M. Gerold, 2002. Oxidative stress and stress activated signaling pathways: A unifying hypothesis of type 2 diabetes. Endocrine Rev., 23: 599-622.
45. Kaji, H., M. Kurasaki and K. Ito, 1985. Increased lipoperoxide value and glutathione peroxidase activity in blood plasma of type 2 diabetic women. KlmWochenschr, 63: 765-768.
46. Kannan, K. and S.K. Jain, 1994. Effect of high glucose on cellular proliferation and Lipid peroxidation in cultured verbo cells. Horm. Met. Res., 26: 322-325.
47. Kataoka, S., J. Satoh, H. Fujiya, T. Toyota, R. Suzuki, K. Itoh and K. Kumagai, 1983. Immunologic aspects of the nonobese diabetic (NOD) mouse. Abnormalities of cellular immunity. Diabetes, 32: 247-253.
48. Kinlaw, W.B., A.S. Levine, J.E. Morley, S.E. Silvis and C.J. McClain, 1983. Abnormal zinc metabolism in type 2 diabetes mellitus. Am. J. Med., 75: 273-277.
49. Like, A.A., A.A. Rossini, D.L. Guberski, M.C. Appel and R.M. Williams, 1979. Spontaneous diabetes mellitus: Reversal and prevention in the BB/W rat with antiserum to rat lymphocytes. Sci., 206: 1421-1423.
50. MacRury, S.M., D. Gordon, R. Wilson, H. Bradley and C.G. Gemmell et al, 1993. A comparison of different methods of assessing free radical activity in type 2 diabetes and peripheral vascular disease. Diabet. Med., 10: 331-335.
51. Maharjan, B.R., J.C. Jha, D. Adhikari, P. Vishwanath, J. Baxi, V.M. Alurkar and P.P. Singh, 2008. A study of oxidative stress, antioxidant status and lipid profile in diabetic patient in the western region of Nepal. KathmanduUni. Med. J., 6: 16-22.
52. Maritim, A.C., R.A. Sanders and J.B. Watkins, 2003. Diabetes, oxidative stres and antioxidants: A review. J. Biochem. Mol. Toxicol, 17: 24-38.
53. Marjani, A., 2005. Age-related alterations of plasma lipid peroxidation and erythrocyte superoxide dismutase activity in different age groups of Gorgan City, Iran. Saudi Med. J., 26: 1647-1648.
54. Marjani, A., 2006. Plasma zinc and magnesium levels in type 2 diabetic patients in Gorgan city (South East of Caspian Sea-Iran). J. Medical Sci., 6: 1029-1032.
55. Marjani, A., A. Moradi and M. Saeedi, 2007. Plasma lipid peroxidation zinc and erythrocyte Cu-Zn superoxide dismutase enzyme activity in patients with type 2 diabetes mellitus in Gorgan city (South East of the Caspian Sea). J. Medical Sci., 7: 585-590.
56. Marjania, A., G. Veghari and M.T. Badeleh, 2010. Serum lipid peroxidation and leptin levels in male and female type 2 diabetic patients in Gorgan (South East of Caspian Sea), Iran. J. Chin. Clin. Med., 5: 26-35.
57. Memisogullari, R, S. Taysi, E. Bakan and I. Capoglu, 2003. Antioxidant status and lipid peroxidation in type 2 diabetes mellitus. Cell Biochem. Funct, 21: 291-296.
58. Midaoui, A.E. and J. Champlain, 2005. Effects of glucose and insulin on the development of oxidative stress and hypertension in animal models of type 1 and type 2 diabetes. J. Hypertension, 23: 581-588.
59. Mocchegianai, E., M. Boemi, P. Fumelli and N. Fabris, 1989. Zinc-dependent low thymic hormone level in type 1 diabetes. Diabetes, 38: 932-937.
60. Mooradian, A.D., M. Failla, B. Hoogwerf, M. Marynuik and J. Wylie-Roset, 1994. Selected vitamins and minerals in diabetes. Diabetes Care, 17: 464-479.
61. Nath, N, S.N. Chan and A.B. Rathi, 1994. Superoxide dismutase in diabetic polymorphonuclear leukocytes. Diabetes, 33: 586-589.
62. Neri, S., CM. Bruno, C. Raciti, G. Dangelo, R. Damico and R. Cristaldi, 1994. Alteration of oxide reductive and haemostatic factors in type 2 diabetics. J. Intern. Med., 336: 495-500.
63. Niki, E., Y. Yoshida, Y. Saito and N. Noguchi, 2005. Lipid peroxidation: Mechanisms, inhibition and biological effects. Biochem. Biophys. Res. Commun., 338: 668-676.
64. Nishigaki, J., M. Hagihara, H. Tsunekawa, M. Maseki and K. Yagi, 1981. Lipid peroxide levels of serum lipoprotein fractions of diabetic proteins. Biochem. Med., 25: 373-378.
65. Niskanen, Dr. L.K., J.T. Salonen, K. Nyyssonen and M.I. J. Uusitupa, 1995. Plasma lipid peroxidation and hyperglycaemia: A connection through hyperinsulinaemia? Diabet. Med., 12: 802-808.
66. Nourooz-Zadeh, J., A. Rahimi, J. Tajaddini-Sarmadi, H. Tritschler, P. Rosen, B. Halliwel and D.J. Betteridge, 1997. Relationships between plasma measures of oxidative stress and metabolic control in NIDDM. Diabetologica, 40: 647-653.
67. Obrosova, I.G., C. Vanteysen, L. Fathallah, X. Cao, D.A. Greene and M.J. Stevens, 2002. An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function. FASEB J., 16: 123-125.
68. Paik, S.G., M.L. Blue, N. Fleischer and S. Shin, 1982. Diabetes susceptibility of BALB/cBOM mice treated with streptozotocin. Inhibition by lethal irradiation and restoration by splenic lymphocytes. Diabetes, 31: 808-815.
69. Palanduz, S., E. Ademoglu, C. Gokkusu and S. Tamer, 2001. Plasma antioxidants and type 2 diabetes mellitus. Res. Commun. Mol. Pathol. Pharmacol., 109: 309-318.
70. Paul, RR, J. Harmon, P.O. Tran and V. Poitout, 2004. Beta cell glucose toxicity and chronic oxidative stress in type 2 diabetes. Diabetes, 53: S119-S124.
71. Ravina, A., L. Slezak, N. Mirsky, N. Bryden and R.A. Anderson, 1999. Reversal of corticosteroid-induced diabetes mellitus with supplemental chromium. Diabet. Med., 16: 164-167.
72. Rerup, C.C., 1970. Drugs producing diabetes through damage of insulin secreting cells. Pharmacol. Rev., 22: 485-518.
73. Ruiz, C, Alegria, R. Barbera, R. Farre and M.J. Lagarda, 1998. Selenium, zinc and copper in plasma of patients with type 1 diabetes mellitus in different metabolic control states. J. Trace Elem. Med. Biol, 12: 91-95.
74. Sandler, S., A.K. Andersson, A. Barbu, C. Hellerstrom and M. Holstad et al., 2000. Novel experimental strategies to prevent the development of type 1 diabetes mellitus. Ups. J. Med. Sci., 105: 17-34.
75. Santini, S.A., G. Marra, B. Giardina, P. Controneo and A. Mordente et al., 1997. Defective plasma antioxidant defenses and enhanced susceptibility to lipid peroxidation in u ncomplicated IDDM. Diabetes, 46: 1853-1858.
76. Satoa, Y., N. Hotta, N. Sakamoto, S. Matsuoka, N. Ohishi and K. Yagi, 1979. Lipid peroxide level in plasma of diabetic patients. Biochem. Med., 21: 104-107.
77. Satohb, K., 1978. Serum lipid peroxide in cerebrovascular disorders determined by new colorimetric method. Clin. Chun. Acta., 90: 37-43.
78. Sharma, A., S. Kharb, S.N. Chug, R. Kakkar and G.P. Singh, 2000. Elevation of oxidative stress before and after control of glycemia and after vitamin E supplementation in diabetic patients. Metabolism, 49: 160-162.
79. Shewade, Y., S. Tirth and R.R. Bhonde, 2001. Pancreatic islet-cell viability, functionality and oxidative status remain unaffected at pharmacological concentrations of commonly used antibiotics in vitro. J. Biosci., 26: 349-355.
80. Singh, P.P., S. Gupta, M.K. Barjatiya, G.P. Mamtha and D. Adhikari, 2007. Oxidant Antioxidant Dovetail Hypothesis: Let us not Sprint Before We Stand. In: Free Radicals and Antioxidants in Health and Disease, Singh, P.P. (Eds.), Chaudhary Offset Print, Udaipur, India, pp: 1-31.
81. Stark, G., 2005. Functional consequences of oxidative membrane damage. J. Membr. Biol., 205: 1-16.
82. Sumovski, W., H. Baquerizo and A. Rabinovich, 1992. Oxygen free radical scavenger protect rat islet cells from damage by cytokines. Diabetelogica, 32: 792-796.
83. Sundaram, R.K., A. Bhaskar, S. Vijayalingam, M. Viswanathan, R. Mohan and K.R. Shanmugasundaram, 1996. Antioxidant status and lipid peroxidation in type 2 diabetes mellitus with and without complications. Clin. Sci., 90: 255-260.
84. Tsai, E.C., LB. Hirsch, J.D. Brunzell and A. Chait, 1994. Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. Diabetes, 43: 1010-1014.
85. Turk, H.M., A. Sevinc, C. Camci, A. Cigli, S. Buyukberber, H. Savli and N. Bayraktar, 2002. Plasma lipid peroxidation products and antioxidant enzyme activities in patients with type 2 diabetes mellitus. Acta Diabetol, 39: 117-122.
86. Valko, M., D. Leibfritz, J. Moncol, M. Cronin, M. Mazur and J. Telser, 2007. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol., 39: 44-84.
87. Van Dam, P.S., B.S. Van Asbeck, D.W. Erkelens, J.J.M. Marx, W.H. Gispen and B. Bravenboer, 1995. The role of oxidative stress in neuropathy and other diabetic complications Diabet. Metab. Rev., 11: 181-192.
88. Vanizor, B., A. Orem, S.C. Karahan, K. Emine, E. Cihangir, A. Rezzan and U. Huseyin Avni, 2001. Decreased nitric oxide end-products its relationship with high density lipoprotein and oxidative stress in people with type 2 diabetes without complications. Diabetes Res. Clin.,Pract.,54: 33-39.
89. Veghari, V., A. Marjani and H.R. Joshaghani, 2007. The study of diabetes mellitus in Gorgan, Iran. Saudi Med. J., 28: 1300-1301.
90. Velazquez, E., P.H. Winocour, P. Kesteven, K.G. Alberti and M.F. Laker, 1991. Relation of lipid peroxides to macrovascular disease in type 2 diabetes. Diabet. Med., 8: 752-758.
91. Walter, R.M., J.Y. Unu-Hare, K.L. Olm, M.H. Oster and B.D. Anawalt et al., 1991. Copper, zinc, magnesium status and complications of diabetes mellitus. Diabetes Care, 14: 1050-1056.
92. West, I.C, 2000. Radicals and oxidative stress in diabetes. DiabetMed., 17: 171-180.
93. Wolff, S.P., Z.Y. Jiang and J.V. Hunt 1991- Protein glycation and oxidative stress in diabetes mellitus and ageing. FreeRad. Biol. Med., 10: 339-352.
94. Zargar, A.H., N.A. Shah, S.R. Massodi, B.A. Laway and F.A. Dar et al., 1998. Copper, zinc and magnesium levels in non insulin dependent diabetes mellitus. Postgrad. Med. J., 74: 665-668.